PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 17, 2026Lara D. Veeken0 citationsOpen Access

Before calling it FMF: MEFV variants of uncertain significance in autoinflammatory disease

View Full Paper
VCVeysel CamECE. CingozHEHülya Ercan Emreol

Key Points

  • The study aims to describe clinical characteristics of patients with MEFV variants of uncertain significance compared to those with pathogenic variants.
  • Retrospective study of pediatric patients with recurrent autoinflammatory manifestations receiving colchicine and undergoing MEFV genetic analysis.
  • Patients were stratified by MEFV genotype for comparison of clinical features, attack characteristics, and treatment profiles.
  • Patients with MEFV VUS showed fewer classical FMF features like serositis-related chest pain and arthritis.
  • Atypical manifestations such as diarrhea, oral aphthae, and lymphadenopathy were observed more frequently in patients with VUS.
  • Approximately half of the patients with VUS fulfilled FMF classification criteria.

Abstract

OBJECTIVES: Familial Mediterranean fever (FMF) is an autoinflammatory disease characterized by recurrent febrile attacks and serositis, with a high prevalence and carrier frequency of MEFV variants in Eastern Mediterranean populations. In this setting, interpretation of MEFV variants of uncertain significance (VUS) is challenging, and their clinical relevance remains controversial. We aimed to describe the clinical characteristics of patients carrying mono- or biallelic MEFV VUS and to compare them with patients harboring biallelic pathogenic MEFV variants, including assessment of FMF and PFAPA classification according to Eurofever/PRINTO criteria. METHODS: This retrospective study included pediatric patients with recurrent autoinflammatory manifestations who underwent MEFV genetic analysis and were receiving colchicine. Patients were stratified by MEFV genotype, and clinical features, attack characteristics, treatment profiles, and classification status were compared. RESULTS: Patients with MEFV VUS exhibited fewer classical FMF features, such as serositis-related chest pain and arthritis, but more frequent atypical manifestations, including diarrhea, oral aphthae, and lymphadenopathy, along with longer attack duration. Measures of disease burden, including age at onset and attack frequency, were similar between groups. FMF criteria were fulfilled by approximately half of patients with VUS. CONCLUSION: Patients with autoinflammatory disease carrying MEFV variants of uncertain significance may exhibit atypical clinical features. Alternative diagnoses should be considered, and further genetic evaluation may be required.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Cam et al. (2026) studied this question.

synapsesocial.com/papers/6a095bef7880e6d24efe1d89https://doi.org/10.1093/rheumatology/keag252
Ask AI
Helpful
Bookmark
Share
View Full Paper